Treating Chronic Myeloid Leukemia Improving Management Through Understanding of the Patient Experience

The Chronic Myelogenous Leukemia (CML) Society of Canada is pleased to provide open access to the paper, “Treating Chronic Myeloid Leukemia – Improving Management Through Understanding of the Patient Experience”.

The paper is written by Cheryl-Anne Simoneau, BA, who is the president and chief executive officer of the Chronic Myeloid Leukemia Society of Canada. Writing and editorial support were provided by Anita Engh, PhD, at Stem Scientific with funding from Bristol-Myers Squibb.  The author takes full responsibility for the content of the article. The author did not receive honoraria for this work. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias.

While the abstract to the article can also be found in the Clinical Journal of Oncology Nursing, with access provided to subscribers of the publication or by paying a small access fee, The CML Society of Canada has secured the licensing rights to provide the paper in its entirety to patients for a period of two (2) years exclusively through our website.

If you are a fellow Patient Group and you want to make this paper available to your patients may we ask that in order to protect certain rights, you provide a link on your website to this page of our website and not directly to the article.  Thank you for your understanding and cooperation.

Treating Chronic Myeloid Leukemia – Improving Management Through Understanding of the Patient Experience

Please feel free to provide us feedback on the article, your comments will be appreciated.






Comments are closed .